Literature DB >> 17055049

Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders.

Akira Shimada1, Yasuhide Hayashi, Mizuho Ogasawara, Myoung-Ja Park, Masahiko Katoh, Hisanori Minakami, Toshiyuki Kitoh, Seiji Kojima, Keisei Kawa, Hirokazu Kimura.   

Abstract

Down syndrome (DS) patients are frequently complicated with infections, autoimmune phenomena and hematological disorders, including transient abnormal myelopoiesis (TAM) in infancy and acute megakaryoblastic leukaemia (AMKL) in later life. In this study, serum levels of cytokines from 23 TAM and 15 AMKL patients were examined using the highly sensitive microsphere fluorescence system. Statistical differences between DS neonates with or without TAM were found in IL-1beta [median 7.0 pg/ml (0.34-271.6) verses 0.05 pg/ml (0.0-2.4), p=0.034], TNF-alpha [8.11 pg/ml (0.1-253.0) verses 0.41 pg/ml (0.1-1.5), p=0.041], and IFN-gamma [20.0 pg/ml (0.14-406.3) verses 1.5 pg/ml (0.14-5.79), p=0.036]. Moreover, abnormal inflammatory cytokinemia was also found in myelodysplastic syndrome (MDS) and AMKL with DS. These abnormal cytokinemia may have a role in the pathophysiology of TAM, MDS and AMKL in DS, especially in liver fibrosis or myelofibrosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055049     DOI: 10.1016/j.leukres.2006.09.008

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

1.  Liver disease is frequently observed in Down syndrome patients with transient abnormal myelopoiesis.

Authors:  Myoung Ja Park; Manabu Sotomatsu; Kentaro Ohki; Kokoro Arai; Kenichi Maruyama; Tomio Kobayashi; Akira Nishi; Kiyoko Sameshima; Takeshi Takagi; Yasuhide Hayashi
Journal:  Int J Hematol       Date:  2013-12-14       Impact factor: 2.490

2.  DYRK1A phoshorylates histone H3 to differentially regulate the binding of HP1 isoforms and antagonize HP1-mediated transcriptional repression.

Authors:  Suk Min Jang; Saliha Azebi; Guillaume Soubigou; Christian Muchardt
Journal:  EMBO Rep       Date:  2014-05-12       Impact factor: 8.807

3.  Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis.

Authors:  Yan Zhang; Meng Che; Jing Yuan; Yun Yu; Chang Cao; Xiao-Yan Qin; Yong Cheng
Journal:  Oncotarget       Date:  2017-09-19

4.  Altered pro-inflammatory and anti-inflammatory plasma cytokines levels in children with Down's syndrome: A meta-analysis.

Authors:  Nitu Nigam; Prithvi K Singh; Neena Raizada; Balendra P Singh; Shalini Tripathi; Monica Agrawal; Harish Gupta; Sharad Singh; Ghizal Fatima; Sanjay K Nigam; Shailendra K Saxena
Journal:  J Family Med Prim Care       Date:  2021-11-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.